The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys

被引:1519
作者
Stremlau, M
Owens, CM
Perron, MJ
Kiessling, M
Autissier, P
Sodroski, J [1 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Dept Pathol, Div Aids, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Dept Med, Div Aids, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
D O I
10.1038/nature02343
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Host cell barriers to the early phase of immunodeficiency virus replication explain the current distribution of these viruses among human and non-human primate species(1-4). Human immunodeficiency virus type 1 (HIV-1), the cause of acquired immunodeficiency syndrome ( AIDS) in humans, efficiently enters the cells of Old World monkeys but encounters a block before reverse transcription(2-4). This species-specific restriction acts on the incoming HIV-1 capsid(5-7) and is mediated by a dominant repressive factor(7-9). Here we identify TRIM5alpha, a component of cytoplasmic bodies, as the blocking factor. HIV-1 infection is restricted more efficiently by rhesus monkey TRIM5alpha than by human TRIM5alpha. The simian immunodeficiency virus, which naturally infects Old World monkeys(10), is less susceptible to the TRIM5alpha-mediated block than is HIV-1, and this difference in susceptibility is due to the viral capsid. The early block to HIV-1 infection in monkey cells is relieved by interference with TRIM5alpha expression. Our studies identify TRIM5alpha as a species-specific mediator of innate cellular resistance to HIV-1 and reveal host cell components that modulate the uncoating of a retroviral capsid.
引用
收藏
页码:848 / 853
页数:6
相关论文
共 30 条
[1]   Restriction of lentivirus in monkeys [J].
Besnier, C ;
Takeuchi, Y ;
Towers, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11920-11925
[2]   Effects of promyelocytic leukemia protein on virus-host balance [J].
Bonilla, WV ;
Pinschewer, DD ;
Klenerman, P ;
Rousson, V ;
Gaboli, M ;
Pandolfi, PP ;
Zinkernagel, RM ;
Salvato, MS ;
Hengartner, H .
JOURNAL OF VIROLOGY, 2002, 76 (08) :3810-3818
[3]   RING fingers and B-boxes: zinc-binding protein-protein interaction domains [J].
Borden, KLB .
BIOCHEMISTRY AND CELL BIOLOGY, 1998, 76 (2-3) :351-358
[4]   A quantitative assay for HIV DNA integration in vivo [J].
Butler, SL ;
Hansen, MST ;
Bushman, FD .
NATURE MEDICINE, 2001, 7 (05) :631-634
[5]   Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects [J].
Chee, AV ;
Lopez, P ;
Pandolfi, PP ;
Roizman, B .
JOURNAL OF VIROLOGY, 2003, 77 (12) :7101-7105
[6]   Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism [J].
Cowan, S ;
Hatziioannou, T ;
Cunningham, T ;
Muesing, MA ;
Gottlinger, HG ;
Bieniasz, PD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11914-11919
[7]   The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811 [J].
Dorfman, T ;
Gottlinger, HG .
JOURNAL OF VIROLOGY, 1996, 70 (09) :5751-5757
[8]   Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1 [J].
Fassati, A ;
Goff, SP .
JOURNAL OF VIROLOGY, 2001, 75 (08) :3626-3635
[9]   HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor [J].
Feng, Yu ;
Broder, Christopher C. ;
Kennedy, Paul E. ;
Berger, Edward A. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (11) :872-877
[10]   Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication [J].
Forshey, BM ;
von Schwedler, U ;
Sundquist, WI ;
Aiken, C .
JOURNAL OF VIROLOGY, 2002, 76 (11) :5667-5677